Michael V. O'Shaughnessy


Michael O'Shaughnessy

Washington, D.C.

P: +1.202.639.7716 F: +1.202.508.9333
  • Advised Novartis Vaccines & Diagnostics in license negotiations and patent enforcement actions
  • Represented Amgen in patent infringement and validity action relating to PCSK9 inhibitors
  • Represented Unified Patents in Inter Partes Review proceedings before the Patent Trial and Appeals Board
  • Represented Kemin Industries in a patent infringement dispute relating to occular antiopxidants at the International Trade Commission
  • Represented Boston Scientific in litigations relating to implantable cardioverter defibrillators and pacemakers, including an appeal before the U.S. Court of Appeals for the Federal Circuit; opposed a petition for a writ of certiorari before the U.S. Supreme Court
  • Advised Philips Corp. in a license deal valued at $100 million relating to surgical instruments
  • Represented Guidant Corp. and Advanced Cardiovascular Systems in several litigations involving coronary stents, including a jury trial; received a favorable jury verdict of infringement for Guidant
  • Represented Wyeth in Hatch-Waxman litigation in the U.S. District Court for the District of Delaware, granted favorable settlement terms for Wyeth
  • Authored appellate briefs and twice presented oral argument before the U.S. Court of Appeals for the District of Columbia Circuit